Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels

NCT01364623 is registered in ClinicalTrials.gov with Acerus Pharmaceuticals Corporation as lead sponsor.

NCT NCT01364623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01364623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels
Lead sponsor
Acerus Pharmaceuticals Corporation
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2011
Completion date
February 29, 2012
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female sexual dysfunction